SIM
SNDX icon

Sandia Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Sandia Investment Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,000
Closed -$43.6K – 200
2023
Q3 		$43.6K Sell
3,000
-2,000
-40% -$37.8K 0.01% 178
2023
Q2 		$105K Hold
5,000
– – 0.02% 153
2023
Q1 		$106K Hold
5,000
– – 0.02% 169
2022
Q4 		$127K Buy
+5,000
New +$117K 0.02% 158

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Sandia Investment Management's SNDX Position: Q4 2023 in Review

Sandia Investment Management sold out of Syndax Pharmaceuticals (SNDX) in Q4 2023, closing a stake of 3,000 shares — an estimated $43.6K sold.

Sandia Investment Management first reported a position in SNDX in Q4 2022 and held it in 4 quarters. The position peaked at $127K in Q4 2022. 177 funds tracked by Wall St. Rank hold SNDX as of Q4 2023.

  • Sandia Investment Management reported no remaining Syndax Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Sandia Investment Management sold 3,000 Syndax Pharmaceuticals shares in Q4 2023, an estimated $43.6K.
  • Sandia Investment Management first reported a position in Syndax Pharmaceuticals in Q4 2022 and held it in 4 quarters.
  • Sandia Investment Management's Syndax Pharmaceuticals position peaked at $127K in Q4 2022.
  • 177 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2023.

Based on Sandia Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.